Abstract
Intensive care unit (ICU) admission is associated with high mortality in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Whether mortality has decreased recently is unknown. The 497 adult allogeneic HSCT recipients admitted to three ICUs between 1997 and 2011 were evaluated retrospectively. Two hundred and nine patients admitted between 1997 and 2003 were compared with the 288 patients admitted from 2004 to 2011. Factors associated with 90-day mortality were identified. The recent cohort was characterized by older age, lower conditioning intensity, and greater use of peripheral blood or unrelated-donor graft. In the recent cohort, ICU was used more often for patients in hematological remission (67% vs 44%; P<0.0001) and without GVHD (73% vs 48%; P<0.0001) or invasive fungal infection (85% vs 73%; P=0.0003) despite a stable admission rate (21.7%). These changes were associated with significantly better 90-day survival (49% vs 31%). Independent predictors of hospital mortality were GVHD, mechanical ventilation (MV) and renal replacement therapy (RRT). Among patients who required MV or RRT, survival was 29% and 18%, respectively, but dropped to 18% and 6% in those with GVHD. The use of ICU admission has changed and translated into improved survival, but advanced life support in patients with GVHD usually provides no benefits.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gratwohl A, Baldomero H, Gratwohl M, Aljurf M, Bouzas LF, Horowitz M et al. Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. Haematologica 2013; 98: 1282–1290.
Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008; 111: 1827–1833.
Chang C, Storer BE, Scott BL, Bryant EM, Shulman HM, Flowers ME et al. Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders. Blood 2007; 110: 1379–1387.
Scheinberg P, Young NS . How I treat acquired aplastic anemia. Blood 2012; 120: 1185–1196.
Carella AM, Cavaliere M, Lerma E, Ferrara R, Tedeschi L, Romanelli A et al. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin’s disease and non-Hodgkin’s lymphoma. J Clin Oncol 2000; 18: 3918–3924.
Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA . Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531–540.
Socié G, Blazar BR . Acute graft-versus-host disease: from the bench to the bedside. Blood 2009; 114: 4327–4336.
Afessa B, Azoulay E . Critical care of the hematopoietic stem cell transplant recipient. Crit Care Clin 2010; 26: 133–150.
Pène F, Aubron C, Azoulay E, Blot F, Thiéry G, Raynard B et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24: 643–649.
Soubani AO, Kseibi E, Bander JJ, Klein JL, Khanchandani G, Ahmed HP et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 2004; 126: 1604–1611.
Afessa B, Tefferi A, Dunn WF, Litzow MR, Peters SG . Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med 2003; 31: 1715–1721.
Price KJ, Thall PF, Kish SK, Shannon VR, Andersson BS . Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 1998; 158: 876–884.
Groeger JS, Lemeshow S, Price K, Nierman DM, White P Jr, Klar J et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 1998; 16: 761–770.
Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091–2101.
Bayraktar UD, Shpall EJ, Liu P, Ciurea SO, Rondon G, de Lima M et al. Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol 2013; 31: 4207–4214.
Azoulay E, Mokart D, Pène F, Lambert J, Kouatchet A, Mayaux J et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 2013; 31: 2810–2818.
Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 1038–1046.
Lengliné E, Raffoux E, Lemiale V, Darmon M, Canet E, Boissel N et al. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 2012; 53: 1352–1359.
Azoulay E, Soares M, Darmon M, Benoit D, Pastores S, Afessa B . Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care 2011; 1: 5.
Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628–1633.
Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A et al. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transplant 2014; 49: 168–173.
Legrand M, Max A, Peigne V, Mariotte E, Canet E, Debrumetz A et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 2012; 40: 43–49.
De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–1821.
Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997; 97: 855–864.
Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E . The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808–814.
Pasquini MC, Wang Z, Horowitz MM, Gale RP . 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl 2010, 87–105.
Passweg JR, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte RF et al. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant 2013; 48: 1161–1167.
Kawase T, Morishima Y, Matsuo K, Kashiwase K, Inoko H, Saji H et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood 2007; 110: 2235–2241.
Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med 2012; 367: 1487–1496.
Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG . Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc 1992; 67: 117–122.
Benz R, Schanz U, Maggiorini M, Seebach JD, Stussi G . Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplant 2014; 49: 62–65.
Depuydt P, Kerre T, Noens L, Nollet J, Offner F, Decruyenaere J et al. Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience. Bone Marrow Transplant 2011; 46: 1186–1191.
Gilli K, Remberger M, Hjelmqvist H, Ringden O, Mattsson J . Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unit. Bone Marrow Transplant 2010; 45: 682–688.
Scales DC, Thiruchelvam D, Kiss A, Sibbald WJ, Redelmeier DA . Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care 2008; 12: R77.
Moins-Teisserenc H, Busson M, Scieux C, Bajzik V, Cayuela J-M, Clave E et al. Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation. J Infect Dis 2008; 198: 818–826.
Heininger A, Haeberle H, Fischer I, Beck R, Riessen R, Rohde F et al. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 2011; 15: R77.
Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008; 300: 413–422.
Burghi G, Lemiale V, Seguin A, Lambert J, Lacroix C, Canet E et al. Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis. Intensive Care Med 2011; 37: 1605–1612.
Adda M, Coquet I, Darmon M, Thiery G, Schlemmer B, Azoulay E . Predictors of noninvasive ventilation failure in patients with hematologic malignancy and acute respiratory failure. Crit Care Med 2008; 36: 2766–2772.
Singh N, McNeely J, Parikh S, Bhinder A, Rovin BH, Shidham G . Kidney complications of hematopoietic stem cell transplantation. Am J Kidney Dis 2013; 61: 809–821.
Canet E, Lengline E, Zafrani L, Peraldi M-N, Socié G, Azoulay E . Acute Kidney Injury in critically ill Allo-HSCT recipients. Bone Marrow Transplant 2014; 49: 1121–1122.
Zuber B, Tran T-C, Aegerter P, Grimaldi D, Charpentier J, Guidet B et al. Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 2012; 40: 55–62.
Acknowledgements
This work was supported by the Groupe de Recherche en Réanimation Oncohématologique (Grrr-OH).
Author Contributions
EA coordinated the research; EL, ASM, FP and FB collected and assembled the data; SC performed the statistical analysis; all authors analyzed the data and approved the final manuscript. EL and EA wrote the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Bone Marrow Transplantation website
Supplementary information
Rights and permissions
About this article
Cite this article
Lengliné, E., Chevret, S., Moreau, AS. et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 50, 840–845 (2015). https://doi.org/10.1038/bmt.2015.55
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2015.55
This article is cited by
-
AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients
Bone Marrow Transplantation (2024)
-
Impact of pre-transplant individual comorbidities on risk of ICU admission and survival outcomes following allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation (2023)
-
Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients
Bone Marrow Transplantation (2023)
-
Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes—results of a retrospective analysis from a German university hospital
Annals of Hematology (2022)
-
Clinical diagnostic accuracy of respiratory failure in critically ill hematopoietic stem cell transplant patients
International Journal of Hematology (2022)